Five Key Facts About Bio-Tissue


As we begin the new year, we wanted to share some key facts about Bio-Tissue. As one of five companies to be profiled as “One to Watch” in the year-end issue of Advanced Ocular Care, we continue our focus to provide groundbreaking regenerative solutions to eye care practitioners and patients around the world. Here are five key facts:

A Year of New Developments


Our company implemented many key initiatives this year in our continued effort to bring innovative regenerative solutions to eye care professionals around the world. As 2016 nears the end, following are just a few of these key efforts:

A History of Innovation


Recently I had the pleasure of accepting the prestigious Tibbetts Award on behalf of TissueTech™ (parent company of Bio-Tissue and Amniox Medical) for the Company’s significant achievements in regenerative medicine. Maria Contreras-Sweet, Administrator, U.S. Small Business Administration (SBA), presented the award at a White House ceremony, and I was honored to be among the other 22 companies recognized out of thousands of applicants.

TissueTech received its first Small Business Innovation Research (SBIR) grant in 2003, and since then the Company has received 11 SBIR grants that have helped to support its growth and led us to being at the forefront of innovation in regenerative medicine. Our history of federal funding through SBIR and the National Institutes of Health (NIH) has been instrumental in the development of many innovative products that are used worldwide by doctors in ophthalmology and optometry as well as orthopedics and chronic wound care.